Safety of biological therapies in ulcerative colitis: An umbrella review of meta-analyses

This publication has 21 references indexed in Scilit:

• Summarizing systematic reviews
  JBI Evidence Implementation, 2015
• Clinical Practice Guidelines for the Medical Management of Nonhospitalized Ulcerative Colitis: The Toronto Consensus
  Gastroenterology, 2015
• Efficacy of tumour necrosis factor antagonists on remission, colectomy and hospitalisations in ulcerative colitis: Meta-analysis of placebo-controlled trials
  Digestive and Liver Disease, 2015
• Systematic review and meta‐analysis: opportunistic infections and malignancies during treatment with anti‐integrin antibodies in inflammatory bowel disease
  Alimentary Pharmacology & Therapeutics, 2015
• PRISMA—Efficacy and Safety of Vedolizumab for Inflammatory Bowel Diseases
  Medicine, 2014
• Biological Agents for Moderately to Severely Active Ulcerative Colitis
  Annals of Internal Medicine, 2014
• Systematic review with meta‐analysis: malignancies with anti‐tumour necrosis factor‐α therapy in inflammatory bowel disease
  Alimentary Pharmacology & Therapeutics, 2014
• Ulcerative Colitis
  New England Journal of Medicine, 2011
• Integration of evidence from multiple meta-analyses: a primer on umbrella reviews, treatment networks and multiple treatments meta-analyses
  Canadian Medical Association Journal, 2009
• Current methods of the U.S. Preventive Services Task Force
  American Journal of Preventive Medicine, 2001